PMID- 24135451 OWN - NLM STAT- MEDLINE DCOM- 20140207 LR - 20171116 IS - 1423-0097 (Electronic) IS - 1018-2438 (Linking) VI - 162 IP - 4 DP - 2013 TI - An increased number of CD4+CD25+ cells induced by an oral administration of Lactobacillus plantarum NRIC0380 are involved in antiallergic activity. PG - 283-9 LID - 10.1159/000354924 [doi] AB - BACKGROUND: Our previous study showed that an oral administration of Lactobacillus plantarum NRIC0380 inhibited immunoglobulin E (IgE) production in a murine model, and that orally administered NRIC0380 induced CD4+CD25+ Foxp3+ T, i.e. regulatory T (Treg), cells in the spleen and Peyer's patch of mice. Although it has been reported that Treg cells might suppress the allergic symptoms, the involvement of the cells in the antiallergic activity of lactic acid bacteria has not been clearly demonstrated. We therefore examined in detail the antiallergic activity of Treg cells obtained from mice that had been fed NRIC0380. METHODS: Treg cells were obtained from mice that had been fed NRIC0380. The T cell-suppressive effect of the cells was analyzed by coculturing the cells with splenocytes of beta-lactoglobulin-immunized mice and beta-lactoglobulin. The effects of the Treg cells on the IgE production and cutaneous anaphylaxis reaction were then analyzed by transferring the cells into another mouse. RESULTS: The Treg cells obtained from the mice that had been fed NRIC0380 showed similar T cell-suppressive activity to those cells obtained from the control mice. The Treg cells obtained from the mice fed NRIC0380 significantly inhibited the IgE production and active cutaneous anaphylaxis reaction when transferred into another mouse that was subsequently immunized with the antigen. Furthermore, the Treg cells also significantly suppressed the passive cutaneous anaphylaxis reaction when cotransferred with the IgE antibody into another mouse. CONCLUSIONS: The induction of Treg cells by the oral administration of NRIC0380 would be involved in the antiallergic activity of NRIC0380. CI - (c) 2013 S. Karger AG, Basel. FAU - Yoshida, Tadashi AU - Yoshida T AD - Department of Applied Biological Science, Tokyo University of Agriculture and Technology, Tokyo, Japan. FAU - Fujiwara, Wataru AU - Fujiwara W FAU - Enomoto, Mai AU - Enomoto M FAU - Nakayama, Sayuri AU - Nakayama S FAU - Matsuda, Hiroshi AU - Matsuda H FAU - Sugiyama, Hisashi AU - Sugiyama H FAU - Shimojoh, Manabu AU - Shimojoh M FAU - Okada, Sanae AU - Okada S FAU - Hattori, Makoto AU - Hattori M LA - eng PT - Journal Article DEP - 20131017 PL - Switzerland TA - Int Arch Allergy Immunol JT - International archives of allergy and immunology JID - 9211652 RN - 0 (Anti-Allergic Agents) RN - 0 (CD4 Antigens) RN - 0 (Interleukin-2 Receptor alpha Subunit) RN - 37341-29-0 (Immunoglobulin E) SB - IM MH - Administration, Oral MH - Animals MH - Anti-Allergic Agents/*administration & dosage/immunology MH - CD4 Antigens/metabolism MH - Immunoglobulin E/biosynthesis/immunology MH - Interleukin-2 Receptor alpha Subunit/metabolism MH - Lactobacillus plantarum/*immunology MH - Mice MH - Mice, Inbred BALB C MH - Passive Cutaneous Anaphylaxis MH - Probiotics/*administration & dosage MH - T-Lymphocytes, Regulatory/*immunology EDAT- 2013/10/19 06:00 MHDA- 2014/02/08 06:00 CRDT- 2013/10/19 06:00 PHST- 2013/03/13 00:00 [received] PHST- 2013/07/15 00:00 [accepted] PHST- 2013/10/19 06:00 [entrez] PHST- 2013/10/19 06:00 [pubmed] PHST- 2014/02/08 06:00 [medline] AID - 000354924 [pii] AID - 10.1159/000354924 [doi] PST - ppublish SO - Int Arch Allergy Immunol. 2013;162(4):283-9. doi: 10.1159/000354924. Epub 2013 Oct 17.